Global $51.5 Billion Antibiotics Markets to 2028: Collaboration Between Pharma Companies is Boosting Industry Growth

DUBLIN, March 10, 2022 /PRNewswire/ -- The "Antibiotics Market Share, Size, Trends, Industry Analysis Report, By Product; By Application: By End-Use; By Region; Segment Forecast, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

The global antibiotics market size is expected to reach USD 51.5 billion by 2028 

The collaboration between pharma companies is boosting industry growth. Pharma companies across the globe are strengthening their research efforts to develop new therapies and to reduce costly burden of drug discovery. In this direction, in July 2019, Nosopharm partnered with Evotec to develop NOSO-502, a novel antibiotic to treat Enterobacteriaceae infections. Similarly, in April 2019, Forge Therapeutics and Basilea Pharma announced research and license agreement to develop new antibiotics.

Moreover, rising public-private collaborations to fund projects related to this industry are also expected to boost market growth. For instance, in March 2019, the Global Antibiotic Research and Development Partnership (GARDP) announced a collaboration with Evotec to develop first-in-class antibiotics for the treatment of drug-resistant bacteria.

Market participants such as Abbott Laboratories, Allergan, Bayer AG, Cumberland Pharmaceuticals, Inc., Danaher, GlaxoSmithKline plc, Melinta Therapeutics, Merck & Co. Inc., Mylan, Nabriva Therapeutics plc, Novartis, Pfizer Inc., Roche , Sanofi, Teva Pharmaceutical Industries Ltd. Pharmaceutical companies across the globe are focusing on research and innovation to stay competitive and develop new anti-microbial therapies.

In line with this, in July 2020, more than dozens of pharma companies introduced AMR action fund, a collaborative effort to develop new three to four antibiotics, by the end of the decade. Group has already collected more than USD 1 billion to support clinical research for new antibiotics to address life-threatening infections.

The fund would provide potential antibiotic candidates for the most challenging drug development stages and enable individual governments to make favourable reforms for potential product pipelines.

Key Topics Covered:

1. Introduction1.1. Report Description1.2. Stakeholders

2. Executive Summary2.1. Market Highlights

3. Research Methodology3.1. Overview3.1.1. Data Mining3.2. Data Sources3.2.1. Primary Sources3.2.2. Secondary Sources

4. Antibiotics Market Insights4.1. Antibiotics Market - Industry Snapshot4.2. Antibiotics Market Dynamics4.2.1. Drivers and Opportunities4.2.2. Restraints and Challenges4.3. Porter's Five Forces Analysis4.4. PESTLE Analysis4.5. Antibiotics Market Industry trends4.6. COVID-19 Impact Analysis

5. Global Antibiotics Market, by Product5.1. Key Findings5.2. Introduction5.2.1. Global Antibiotics Market, by Product, 2016 - 2028 (USD Billion)5.3. Software5.4. Device5.5. Storage System

6. Global Antibiotics Market, by Application6.1. Key Findings6.2. Introduction6.2.1. Global Antibiotics Market, by Application, 2016 - 2028 (USD Billion)6.3. Drug Discovery & Development6.4. Academic research6.5. Disease Diagnosis

7. Global Antibiotics Market , by End-Use7.1. Key Findings7.2. Introduction7.2.1. Global Antibiotics Market, by End-Use, 2016 - 2028 (USD Billion)7.3. Hospitals7.4. Biotech & pharma companies7.5. Diagnostic Labs7.6. Academic & research institutes

8. Global Antibiotics Market, by Geography8.1. Key findings8.2. Introduction8.2.1. Antibiotics Market Assessment, By Geography, 2016 - 2028 (USD Billion)

9. Competitive Landscape9.1. Expansion and Acquisition Analysis9.1.1. Expansion9.1.2. Acquisitions9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles10.1. Company Overview10.2. Financial Performance10.3. Product Benchmarking10.4. Recent Developments

• Abbott Laboratories
• Allergan
• Bayer AG
• Cumberland Pharmaceuticals Inc.
• Danaher
• GlaxoSmithKline plc
• Melinta Therapeutics
• Merck & Co. Inc.
• Mylan
• Nabriva Therapeutics plc
• Novartis
• Pfizer Inc.
• Roche
• Sanofi
• Teva Pharmaceutical Industries Ltd.

For more information about this report visit https://www.researchandmarkets.com/r/6u4wc8

Media Contact:

Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

View original content:https://www.prnewswire.com/news-releases/global-51-5-billion-antibiotics-markets-to-2028-collaboration-between-pharma-companies-is-boosting-industry-growth-301499969.html

SOURCE Research and Markets